Pulmonology Xagena

Xagena Mappa
Xagena Newsletter
Medical Meeting

Search results for "Seebri Breezhaler"

Glycopyrronium bromide ( NVA237; Seebri Breezhaler ) is a once-daily long-acting muscarinic antagonist ( LAMA ) in development for chronic obstructive pulmonary disease ( COPD ). The GLOW2 ( GLyco ...

Glycopyrronium ( Seebri Breezhaler ) is a once daily long-acting muscarinic antagonist that is approved for maintenance treatment of COPD ( chronic obstructive pulmonary disease ). This post-hoc poole ...

Inhaled Glycopyrronium bromide ( Seebri Breezhaler; NVA237 ) is a once-daily, long-acting muscarinic receptor antagonist ( LAMA ) that is approved in several countries, as a maintenance bronchodilator ...